LIVECAST Markets Briefs Calendar Search

Research

AI Market Assistant Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Briefs Calendar Search AI Market Assistant Instrument directory Macro Politics Prediction Markets News Archive Account

Live News REGULATION FLASH L impact Sep 25, 2026, 11:01 AM UTC

Astrazeneca: FDA Action Date For Imfinzi Plus Enfortumab Vedotin Expected In Q4 2026

SquawkNews Newsroom

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

No ticker tags on this item.

Related stories

Firefly Neuroscience, Inc. (AIFF) Partners to Distribute FDA-Cleared Pediatric ADHD Device Firefly Neuroscience announced a partnership with NeuroSigma to introduce the FDA-cleared Monarch eTNS System to Firefly’s Evoke clinician network for eligible pediatric ADHD patie L impact | REGULATION | Sep 25, 2026, 11:48 AM UTC Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD Partnership will introduce NeuroSigma’s second-generation Monarch eTNS® System to Firefly’s nationwide network of Evoke™ clinicians —— Collaboration brings together an FDA-cleared L impact | REGULATION | Sep 25, 2026, 11:48 AM UTC Quantum Cyber sharpens focus on quantum navigation, interceptor drones and U.S. manufacturing Quantum Cyber announced a sharpened strategic focus on quantum navigation, one-way attack/interceptor drones and U.S. manufacturing capacity.Key Highlights:Original SEC Filing: Qua L impact | REGULATION | Sep 25, 2026, 11:44 AM UTC Merck, Eisai Get FDA OK of Welireg/Lenvima Combo in Kidney Cancer By Colin KellaherMerck and Eisai have won U.S. Food and Drug Administration approval of the dual oral regimen of Merck's Welireg plus both companies' Lenvima in certain patients wi L impact | REGULATION | Sep 25, 2026, 11:05 AM UTC FactSet appoints Marcel Prins to its Board of Directors FactSet appointed Marcel Prins as a director, effective September 23, 2026.Original SEC Filing: FACTSET RESEARCH SYSTEMS INC [ FDS ] - 8-K - Sep. 25, 2026This is an AI-powered summ L impact | REGULATION | Sep 25, 2026, 11:04 AM UTC Nektar Therapeutics awarded $90M jury verdict against Eli Lilly over rezpegaldesleukin dispute Nektar Therapeutics won a $90 million jury verdict finding Eli Lilly breached the implied covenant under their rezpegaldesleukin license agreement.Key Highlights:Original SEC Filin L impact | REGULATION | Sep 25, 2026, 11:04 AM UTC

SQUAWK/NEWS

Live financial news for traders. Read the headline on screen or hear it through LiveCast while you stay on the trade.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

Product

Open LiveCast
Plans & Pricing
Institutional API
How LiveCast Works
Live Markets
Session Briefs
RSS Feed
Calendar
Search
Instrument directory

Research

Macro
Politics
Prediction Markets
AI Market Assistant
News Archive

For Traders

Market Movers
US Stocks
Why News Moves Markets
News for Traders
How to Trade the News
What Is an Audio Squawk?
Policy Calendar

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

Legal

Privacy Policy
Terms of Use

© 2026 SquawkNews SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.